Ironwood Pharmaceuticals Overview
Ironwood Pharmaceuticals Target Price
Analysts' 12-month price predictions for IRWD.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.33
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-26 | JefferiesAmy Li | $3.7 |  14.5% downside |  |
| 2026-01-05 | Craig-Hallum | $5.7 |  31.6% upside | |
| 2026-01-04 | Wells Fargo | $5 | 15.5% upside | |
| 2025-11-26 | Craig-Hallum | $3.8 | 12.2% downside | |
| 2025-04-14 | Leerink PartnersFaisal Khurshid | $1 | 76.9% downside | |
| 2025-01-31 | Wells FargoMohit Bansal | $7 | 61.7% upside | |
| 2024-09-09 | Leerink PartnersFaisal Khurshid | $5 | 15.5% upside | |
| 2024-08-09 | Wells FargoMohit Bansal | $12 | 177.1% upside | |
| 2024-05-22 | Piper SandlerDavid Amsellem | $18 | 315.7% upside | |
| 2024-05-22 | Wells FargoMohit Bansal | $14 | 223.3% upside | |
| 2022-04-22 | Piper SandlerDavid Amsellem | $16 | 269.5% upside | |